1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. TEMPEST THERAPEUTICS INC

Tempest Therapeutics Inc

XNAS: TPST

Download real time

6.54 -0.13 (-1.95%)

1495.12% Gain from 52W Low

28,605 XNAS Volume

XNAS 07 May, 2025 1:59 PM (EDT)

Watchlist

Portfolio

Share
12S
7W
4O
1T
23.9

Market Cap

Below industry Median
-0.6

PE TTM

Negative PE TTM
0

PEG TTM

1.2

Price to Book

Below industry Median
-9.0

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Tempest Therapeutics Inc is on 09 May 2025 for the purpose of Tempest Therapeutics Inc First Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Tempest Therapeutics Inc

The latest disclosure was made by Justin Trojanowski in Tempest Therapeutics Inc where a trade of 30,000 Employee Stock Option (right to buy) done was reported to US exchanges on Jan. 2, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Justin Trojanowski Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 30,000 30,000 - - Employee Stock Option (right to buy)
Nicholas Maestas Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 200,000 200,000 - - Employee Stock Option (right to buy)
Samuel Whiting Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 270,000 270,000 - - Employee Stock Option (right to buy)
Stephen R. Brady Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 550,000 550,000 - - Employee Stock Option (right to buy)
Stephen R. Brady Director, President and CEO Purchase of securities on an exchange or from another person at price $ 2.11 per share. 03 Jul 2024 35,000 46,376 - 2.1 73,850 Common Stock
Samuel Whiting Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.13 per share. 02 Jul 2024 4,672 9,573 - 2.1 9,951 Common Stock
Justin Trojanowski Corporate Controller Purchase of securities on an exchange or from another person at price $ 2.16 per share. 28 Jun 2024 7,500 22,168 - 2.2 16,200 Common Stock
Christine A. Pellizzari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 16,000 16,000 - - Stock Option (right to buy)
Geoffrey M. Nichol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 16,000 16,000 - - Stock Option (right to buy)
Michael G. Raab Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 16,000 16,000 - - Stock Option (right to buy)
Ronit Simantov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 16,000 16,000 - - Stock Option (right to buy)
Brady Stephen R. Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2024 250,000 250,000 - - Employee Stock Option (right to buy)
Justin Trojanowski Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2024 26,500 26,500 - - Employee Stock Option (right to buy)
Nicholas Maestas VP of Strategy and Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2024 40,000 40,000 - - Employee Stock Option (right to buy)
Samuel Whiting Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2024 100,000 100,000 - - Employee Stock Option (right to buy)
Geoffrey M. Nichol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 8,200 8,200 - - Stock Option (right to buy)
Christine A. Pellizzari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 8,200 8,200 - - Stock Option (right to buy)
Michael G. Raab Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 8,200 8,200 - - Stock Option (right to buy)
Ronit Simantov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 8,200 8,200 - - Stock Option (right to buy)
Nicholas Maestas VP of Strategy and Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 38,425 38,425 - - Employee Stock Option (right to buy)
Thomas W. Dubensky Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 102,700 102,700 - - Employee Stock Option (right to buy)
Stephen R. Brady Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 177,300 177,300 - - Employee Stock Option (right to buy)
Samuel Whiting Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 69,700 69,700 - - Employee Stock Option (right to buy)
Justin Trojanowski Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 20,300 20,300 - - Employee Stock Option (right to buy)
Justin Trojanowski Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Oct 2022 2,500 2,500 - - Employee Stock Option (right to buy)
Samuel Whiting Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 55,680 55,680 - - Stock Option (Right to Buy)
Nicholas Maestas VP of Strategy and Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 51,270 51,270 - - Stock Option (Right to Buy)
Pierre Lorenzo Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 8,477 8,477 - - Stock Option (Right to Buy)
Thomas W. Dubensky Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 87,801 87,801 - - Stock Option (Right to Buy)
Stephen R. Brady Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 173,533 173,533 - - Stock Option (Right to Buy)
Geoffrey M. Nichol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 3,500 3,500 - - Stock Option (Right to Buy)
Ronit Simantov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 3,500 3,500 - - Stock Option (Right to Buy)
Thomas Woiwode Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 3,500 3,500 - - Stock Option (Right to Buy)
Michael G. Raab Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 3,500 3,500 - - Stock Option (Right to Buy)
Christine A. Pellizzari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 3,500 3,500 - - Stock Option (Right to Buy)
Thomas Woiwode Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.36 per share. 29 Apr 2022 2,118,644 2,118,644 - 2.4 5,000,000 Common Stock
Thomas W. Dubensky Director, President Purchase of securities on an exchange or from another person at price $ 4.78 per share. 07 Jan 2022 2,000 113,343 - 4.8 9,560 Common Stock
Samuel Whiting Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.80 per share. 06 Jan 2022 1,700 1,901 - 4.8 8,168 Common Stock
Nicholas Maestas VP of Strategy and Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 19,500 19,500 - - Stock Option (Right to Buy)
Pierre Lorenzo Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 6,500 6,500 - - Stock Option (Right to Buy)
Samuel Whiting Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 29,000 29,000 - - Stock Option (Right to Buy)
Stephen R. Brady Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 94,500 94,500 - - Stock Option (Right to Buy)
Thomas W. Dubensky Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 53,100 53,100 - - Stock Option (Right to Buy)
Michael G. Raab Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Sep 2021 6,635 6,635 - - Stock Option (Right to Buy)
Ronit Simantov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Aug 2021 6,635 6,635 - - Stock Option (Right to Buy)
Nicholas Maestas VP of Strategy and Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jul 2021 23,225 23,225 - - Stock Option (Right to Buy)
Thomas Woiwode Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 6,635 6,635 - - Stock Option (Right to Buy)
Christine A. Pellizzari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 6,635 6,635 - - Stock Option (Right to Buy)
Geoffrey M. Nichol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 6,635 6,635 - - Stock Option (Right to Buy)
Stella Xu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 6,635 6,635 - - Stock Option (Right to Buy)
Thomas Woiwode Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 1,171,094 1,171,094 - - Common Stock
Michael G. Raab Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 16,784 16,784 - - Stock Option (Right to Buy)
Michael G. Raab Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 4,830 4,830 - - Stock Option (Right to Buy)
Michael G. Raab Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 9,660 9,660 - - Stock Option (Right to Buy)
Thomas W. Dubensky Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 111,343 111,343 - - Common Stock
Thomas W. Dubensky Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 8,050 8,050 - - Stock Option (Right to Buy)
Thomas W. Dubensky Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 45,988 45,988 - - Stock Option (Right to Buy)
Thomas W. Dubensky Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 36,263 36,263 - - Stock Option (Right to Buy)
Thomas W. Dubensky Director, President Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 1,000,000 1,000,000 - - Stock Option (Right to Buy)
Stephen R. Brady Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 1,982,250 1,982,250 - - Stock Option (Right to Buy)
Stephen R. Brady Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 8,050 8,050 - - Stock Option (Right to Buy)
Stephen R. Brady Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 70,256 70,256 - - Stock Option (Right to Buy)
Stephen R. Brady Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 110,432 110,432 - - Stock Option (Right to Buy)
Thomas Woiwode Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 997,940 997,940 - - Common Stock
Pierre Lorenzo Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 48,535 48,535 - - Stock Option (Right to Buy)
Thomas Woiwode Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 7,377 7,377 - - Common Stock
Stella Xu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 579,710 579,710 - - Common Stock
Samuel Whiting Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 540,231 540,231 - - Stock Option (Right to Buy)
Samuel Whiting Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 61,945 61,945 - - Stock Option (Right to Buy)
Samuel Whiting Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 201 201 - - Common Stock
Samuel Whiting Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 3,018 3,018 - - Stock Option (Right to Buy)
Pierre Lorenzo Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 1,234 1,234 - - Stock Option (Right to Buy)
Pierre Lorenzo Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 4,830 4,830 - - Stock Option (Right to Buy)
Pierre Lorenzo Corporate Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 53 53 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters